Colin Broom M.D., CEO & Director at Nabriva Therapeutics plc (NBRV), bought 5,000 shares at $3.72 ($19K) on 2018-06-22, disclosed to the SEC on 2018-06-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| NBRV | SELL | 2020-08-21 | $7K | — | Filing → |
| NBRV | BUY | 2019-09-03 | $21K | — | Filing → |
| NBRV | BUY | 2018-05-23 | $46K | — | Filing → |